Literature DB >> 12215873

[Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults].

P Retz-Junginger1, W Retz, D Blocher, H G Weijers, G E Trott, P H Wender, M Rössler.   

Abstract

This work presents a statistical analysis of the German version of the Wender Utah rating scale (WURS) for the retrospective diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults. Data were obtained from 703 subjects. Item selection according to item-total correlation scores, frequency, and plausibility led to a short version of the scale that includes 21 items with item-total correlations from 0.19 to 0.61. Retest reliability of the WURS-k was r=0.9.

Entities:  

Mesh:

Year:  2002        PMID: 12215873     DOI: 10.1007/s00115-001-1215-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  91 in total

1.  Exploring deficient emotion regulation in adult ADHD: electrophysiological evidence.

Authors:  Anna Shushakova; Patricia Ohrmann; Anya Pedersen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-02       Impact factor: 5.270

2.  [Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist].

Authors:  M Rösler; W Retz; P Retz-Junginger; J Thome; T Supprian; T Nissen; R-D Stieglitz; D Blocher; G Hengesch; G E Trott
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

Review 3.  Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  M Rösler; W Retz; J Thome; M Schneider; R-D Stieglitz; P Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

4.  Binocular rivalry transitions predict inattention symptom severity in adult ADHD.

Authors:  Aiste Jusyte; Natalia Zaretskaya; Nina Maria Höhnle; Andreas Bartels; Michael Schönenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-13       Impact factor: 5.270

5.  ADHD modulates the course of delinquency: a 15-year follow-up study of young incarcerated man.

Authors:  Florence Philipp-Wiegmann; Michael Rösler; Oriana Clasen; Toivo Zinnow; Petra Retz-Junginger; Wolfgang Retz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-13       Impact factor: 5.270

6.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

7.  [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder].

Authors:  P Retz-Junginger; W Retz; D Blocher; R-D Stieglitz; T Georg; T Supprian; P H Wender; M Rösler
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

8.  Neural correlates (ERP/fMRI) of voluntary selection in adult ADHD patients.

Authors:  Susanne Karch; Tobias Thalmeier; Jürgen Lutz; Anja Cerovecki; Markus Opgen-Rhein; Bettina Hock; Gregor Leicht; Kristina Hennig-Fast; Thomas Meindl; Michael Riedel; Christoph Mulert; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-12       Impact factor: 5.270

9.  Cross-sectional evaluation of cognitive functioning in children, adolescents and young adults with ADHD.

Authors:  Ivo Marx; Thomas Hübner; Sabine C Herpertz; Christoph Berger; Erik Reuter; Tilo Kircher; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2009-12-02       Impact factor: 3.575

10.  Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Authors:  Andreas J Fallgatter; Ann-Christine Ehlis; Thomas Dresler; Andreas Reif; Christian P Jacob; Mauricio Arcos-Burgos; Maximilian Muenke; Klaus-Peter Lesch
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-12       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.